.gif)
Tanmay
Dinesh Gawde
1303,
Sai Raj Heights, Sector-20, Plot no. 68, Roadpali, Navi Mumbai-410218
*Corresponding
author: Tanmay Dinesh Gawde, 1303, Sai Raj Heights, Sector-20, Plot
no. 68, Roadpali, Navi Mumbai-410218, E-mail: tanmaygawde311@gmail.com
Citation:
Tanmay Dinesh Gawde, (2020) Ramification of COVID-19 on Clinical Trials with Special Focus on Data
Management and Possible Mitigation Strategies. Clin Biostat Biometr. 1(1); 1-5
Copyright:
© 2020, Tanmay DG, This is an open-access article distributed under the terms
of the Creative Commons Attribution 4.0 International License, which permits
unrestricted use, distribution and reproduction in any medium, provided the
original author and source are credited
ABSTRACT
As
we know how the current COVID-19 Pandemic situation is potentially affecting
all over the globe. Like many other fields it influencing the clinical research
areas as well. As we know the data generated from the clinical trials plays
pivotal role in drug development process. The main source of information is
investigator sites; however, due to current situation it is a strenuous task to
collect and report data from investigator sites. It has increased potential
risks over achieving primary or secondary objectives of the clinical trials.
Considering these challenges, there is need to check for the alternatives,
check for the feasibility of new technologies, new methods of data collections,
think over the mitigation plans and look for the innovations. This is now
become a new vision for many companies, institutes. This article will touch on
few points on how clinical trials and data management system are impacted due
to wake of COVID-19. We will try to throw some light on few mitigation
strategies as well.
KEYWORDS:
Clinical Research, Clinical Data Management, COVID-19,
Electronic Data Capture
.png)
.jpg)